2025년 실제 재무 비교
Endava plc American Depositary Shares (each representing one Class A Ordinary Share) 대 Summit Therapeutics Inc. - Common Stock 재무 비교
바로 답
4개 공통 지표를 같은 GBP 기준으로 비교합니다.
Endava plc American Depositary Shares (each representing one Class A Ordinary Share)의 매출은 772,255,000 GBP입니다.
Summit Therapeutics Inc. - Common Stock의 같은 지표는 0 GBP입니다.
Alpha Vantage의 같은 회계연도 자료를 사용했습니다.
핵심 정보
- Endava plc American Depositary Shares (each representing one Class A Ordinary Share) 매출
- 772,255,000 GBP
- Summit Therapeutics Inc. - Common Stock 매출
- 0 GBP
- Endava plc American Depositary Shares (each representing one Class A Ordinary Share) 영업이익
- 31,507,000 GBP
- Summit Therapeutics Inc. - Common Stock 영업이익
- -1,094,374,000 GBP
- Endava plc American Depositary Shares (each representing one Class A Ordinary Share) 순이익
- 21,212,000 GBP
- Summit Therapeutics Inc. - Common Stock 순이익
- -1,079,586,000 GBP
- Endava plc American Depositary Shares (each representing one Class A Ordinary Share) 영업현금흐름
- 52,773,000 GBP
- Summit Therapeutics Inc. - Common Stock 영업현금흐름
- -239,665,728 GBP